ETUSD Superintendent Sara Haflic speaks with TME about the proposed Phone Free Schools Act To see full stories with photos, ...

Due to the remarkable success of the Research Topic 'New Insights in Veterinary Cancer Immunology' and the rapidly evolving subject area, we are pleased to launch Volume II for this topic. The tumour ...

The U.S. dollar fell to a 17-month low against the Chinese yuan as the Fed cut rates and the PBoC held theirs, highlighting ...

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and ...

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients ...

Millennium Institute of Professional Development MiPD successfully organized its 2-day Annual Principal’s Conference, on the ...

The tumor microenvironment (TME) is a major obstacle that limits effective cancer treatments. Various cells around the tumor promote immunosuppression and | Immunology ...

Significant advancements have been made in targeted cancer therapy in recent years, yet the challenge of overcoming resistance to these treatments in solid tumors persists. The tumor microenvironment ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

Randy Sweis, MD, First Author, Assistant Professor, University of Chicago Medicine Comprehensive Cancer Center The tumor microenvironment (TME) plays a critical role in predicting response to ...

Immunotherapy holds great promise for the future of cancer treatment. By harnessing a patient’s own immune system to target ...

SON-1010 is a targeted immune activation cancer therapy designed to turn ‘cold’ tumors ‘hot’ Topline safety data of SB101 ...